Current machine learning methods struggle to solve Bongard problems, which are a type of IQ test that requires deriving an abstract "concept" from a set of positive and negative "support" images, and then classifying whether or not a new query image depicts the key concept. On Bongard-HOI, a benchmark for natural-image Bongard problems, existing methods have only reached 66% accuracy (where chance is 50%). Low accuracy is often attributed to neural nets' lack of ability to find human-like symbolic rules. In this work, we point out that many existing methods are forfeiting accuracy due to a much simpler problem: they do not incorporate information contained in the support set as a whole, and rely instead on information extracted from individual supports. This is a critical issue, because unlike in few-shot learning tasks concerning object classification, the "key concept" in a typical Bongard problem can only be distinguished using multiple positives and multiple negatives. We explore a variety of simple methods to take this cross-image context into account, and demonstrate substantial gains over prior methods, leading to new state-of-the-art performance on Bongard-LOGO (75.3%) and Bongard-HOI (72.45%) and strong performance on the original Bongard problem set (60.84%).
The field of women's endocrinology has trailed behind data-driven medical solutions, largely due to concerns over the privacy of patient data. Valuable datapoints about hormone levels or menstrual cycling could expose patients who suffer from comorbidities or terminate a pregnancy, violating their privacy. We explore the application of Federated Learning (FL) to predict the optimal drug for patients with polycystic ovary syndrome (PCOS). PCOS is a serious hormonal disorder impacting millions of women worldwide, yet it's poorly understood and its research is stunted by a lack of patient data. We demonstrate that a variety of FL approaches succeed on a synthetic PCOS patient dataset. Our proposed FL models are a tool to access massive quantities of diverse data and identify the most effective treatment option while providing PCOS patients with privacy guarantees.